Aandelen in “Farmaceutische producten: Andere”

Aandeel Datum Koers Evolutie
vlag Revolution Medicines Inc 22/05 151,560 USD
-1,41% 		-1,41%

Nieuws over “Farmaceutische producten: Andere”

25/05 · AB Science announces that its stock continues to be covered by Maxim Group, with a target price of €4.00 per share · Persbericht

25/05 · AB Science announces that its stock continues to be covered by Maxim Group, with a target price of €4.00 per share · Persbericht

22/05 · Prestige Consumer Healthcare, Inc. (PBH) Securities Fraud Investigation - Levi & Korsinsky · Persbericht

22/05 · BioLineRx and Hemispherian AS Highlight New Data on GLIX1 at the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting · Persbericht

21/05 · A LETTER TO PACIRA BIOSCIENCES SHAREHOLDERS FROM DOMA PERPETUAL CAPITAL MANAGEMENT LLC · Persbericht

21/05 · Decibel Reports First Quarter 2026 Results: Quarterly Revenue Grows 41% YoY to $30 Million, Issues Q2 2026 Guidance · Persbericht

20/05 · DOMA Perpetual Director Nominees Send Letter to Shareholders of Pacira Biosciences · Persbericht

20/05 · BioLineRx to Report First Quarter 2026 Results on May 27, 2026 · Persbericht

20/05 · Are KALV, GBTG, MDV, CPRX Obtaining Fair Deals for their Shareholders? · Persbericht

19/05 · Bausch Health Announces 2026 Annual Meeting of Shareholder Results · Persbericht

19/05 · Three TriKE Candidates In Clinic As NK Cell Engager Field Reorganizes · Persbericht

19/05 · Lipocine Announces LPCN 1154 Phase 3 Data Accepted for Oral Presentation at 2026 ASCP Annual Meeting · Persbericht

19/05 · BioLineRx and Hemispherian Announce New GLIX1 Data Demonstrating Potent Anti-Tumor Effect in Glioblastoma (GBM) Across Multiple In-Vivo Studies, Including a Temozolomide (TMZ)-Resistant Model with Patient-Derived Xenografts · Persbericht

18/05 · B7-H3 Becomes The Hottest Antigen In Oncology, And One NK Engager Enters Clinic · Persbericht

18/05 · Lipocine to Present at A.G.P.'s Annual Virtual Healthcare Company Showcase · Persbericht

15/05 · Else Nutrition Reports First Quarter 2026 Results Highlighting Significant Improvement in Gross Margin and Reduced Net Loss · Persbericht

15/05 · MySize Reports 62% Revenue Growth in First Quarter 2026 as Integrated AI Fashion Platform Continues Expansion · Persbericht

14/05 · Are SILA, KALV, THR, LSTA Obtaining Fair Deals for their Shareholders? · Persbericht

14/05 · Galmed Announces Results from First-in-Man Pharmacokinetics Study of Oral Formulation of Aramchol Meglumine (AM); 400mg AM Increases Bioavailability by ~500% in Comparison to Aramchol Free Acid (AA) 300mg · Persbericht

14/05 · Aurora Granted Plant Breeders' Rights, Strengthening Leadership in Cannabis Science · Persbericht

13/05 · AB Science reports its revenues for the year 2025 and provides an update on its activities · Persbericht

Mijn selecties